Litcius/Paper detail

RETRACTED: Dapagliflozin attenuates diabetic cardiomyopathy via NRF2 protein upregulation-driven glutathione synthesis to inhibit myocardial ferroptosis

Xuepin Chen, Tianying Wang, Yan Gao, Guoan Wang, Likun Zhuang, Xi Liu, Li Gong, Mengran Wang, Hongyan Dai, Jun Guan

2025Life Sciences10 citationsDOI

Topics & Concepts

GPX4Downregulation and upregulationDiabetic cardiomyopathyDapagliflozinGene silencingGlutathioneCell biologyProgrammed cell deathLipid peroxidationChemistryOxidative stressPharmacologyCancer researchCardiomyopathyBiologyDiabetes mellitusInternal medicineEndocrinologyApoptosisMedicineBiochemistryHeart failureType 2 diabetesGlutathione peroxidaseEnzymeGeneFerroptosis and cancer prognosisGDF15 and Related BiomarkersImmune cells in cancer
RETRACTED: Dapagliflozin attenuates diabetic cardiomyopathy via NRF2 protein upregulation-driven glutathione synthesis to inhibit myocardial ferroptosis | Litcius